We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+11.15%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$8.8B
AUM Growth
-$819M
(-8.5%)
Cap. Flow
-$1.49B
Cap. Flow
% of AUM
-16.94%
Top 10 Holdings %
Top 10 Hldgs %
37.49%
Holding
1,086
New
112
Increased
123
Reduced
630
Closed
126
Avg Time Held Equity + Options
3.2
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.7
quarters
Avg Time Held Equity only
3.2
quarters
Top 10 Avg Time Held Equity only
0.5
quarters
Top 20 Avg Time Held Equity only
0.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVLR
Avalara, Inc.
AVLR
|
+$364M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$355M |
| 3 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$273M |
| 4 |
STOR
STORE Capital Corporation
STOR
|
+$213M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$463M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$411M |
| 3 |
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$317M |
| 4 |
CDK
CDK Global, Inc.
CDK
|
+$290M |
| 5 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$276M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.43% |
| 2 | Financials | 19.77% |
| 3 | Healthcare | 15.9% |
| 4 | Miscellaneous | 8.89% |
| 5 | Real Estate | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
Haleon
HLN
$41.5B
| $1.12M | 0.01% |
+183,814
| New | +$1.19M |
2022 Q3
0 quarters
|
|
702
EPR Properties
EPR
$4.2B
| $1.11M | 0.01% |
30,989
-10,810
| -26% | -$510K |
2021 Q4
3 quarters
|
|
|
COVA
703
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
| $1.1M | 0.01% |
110,863
-11,098
| -9% | -$110K |
2021 Q3
4 quarters
|
|
704
Oric Pharmaceuticals
ORIC
$1.17B
| $1.1M | 0.01% |
343,002
-18,053
| -5% | -$72.3K |
2022 Q2
1 quarter
|
|
705
DELISTED
iTeos Therapeutics
ITOS
| $1.09M | 0.01% |
57,500
+5,000
| +10% | +$115K |
2022 Q1
2 quarters
|
|
706
Kroger
KR
$35.9B
| $1.09M | 0.01% |
+25,000
| New | +$1.19M |
2022 Q3
0 quarters
|
|
707
Edgewise Therapeutics
EWTX
$3.94B
| $1.09M | 0.01% |
110,750
-14,250
| -11% | -$144K |
2022 Q2
1 quarter
|
|
|
BBBY
708
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.09M | 0.01% |
325,700
+91,500
| +39% | +$745K |
2022 Q1
2 quarters
|
|
709
Lennar Class B
LEN.B
$17.8B
| $1.09M | 0.01% |
19,196
-492
| -2% | -$29.9K |
2022 Q2
1 quarter
|
|
710
Jones Lang LaSalle
JLL
$13.7B
| $1.06M | 0.01% |
7,024
-181
| -3% | -$31.5K |
2022 Q1
2 quarters
|
|
711
Tarsus Pharmaceuticals
TARS
$3.31B
| $1.04M | 0.01% |
+61,000
| New | +$969K |
2022 Q3
0 quarters
|
|
712
DELISTED
HilleVax
HLVX
| $1.04M | 0.01% |
60,943
-30,000
| -33% | -$436K |
2022 Q2
1 quarter
|
|
713
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.03M | 0.01% |
36,534
-3,000
| -8% | -$83.6K |
2022 Q1
2 quarters
|
|
714
DELISTED
Ventyx Biosciences
VTYX
| $1.03M | 0.01% |
+29,400
| New | +$651K |
2022 Q3
0 quarters
|
|
715
Adaptive Biotechnologies
ADPT
$4.03B
| $1.02M | 0.01% |
143,490
-70,000
| -33% | -$659K |
2022 Q1
2 quarters
|
|
716
NRG Energy
NRG
$22.5B
| $1.02M | 0.01% |
26,623
-18,700
| -41% | -$746K |
2022 Q1
2 quarters
|
|
717
Arcus Biosciences
RCUS
$2.87B
| $1.01M | 0.01% |
38,725
-11,700
| -23% | -$309K |
2022 Q2
1 quarter
|
|
718
OGE Energy
OGE
$9.75B
| $1.01M | 0.01% |
+27,587
| New | +$1.11M |
2022 Q3
0 quarters
|
|
719
Establishment Labs
ESTA
$1.74B
| $979K | 0.01% |
17,926
-11,500
| -39% | -$687K |
2022 Q1
2 quarters
|
|
720
PUT
United Airlines
UAL
$33.5B
| $976K | 0.01% |
361,200
| – | – |
2021 Q4
3 quarters
|
|
721
Wayfair
W
$14.8B
| $960K | 0.01% |
+29,500
| New | +$1.56M |
2022 Q3
0 quarters
|
|
722
enVVeno Medical
NVNO
$5.54M
| $940K | 0.01% |
4,278
+903
| +27% | +$192K |
2022 Q1
2 quarters
|
|
|
ASAX
723
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
| $939K | 0.01% |
95,450
-9,555
| -9% | -$94.1K |
2021 Q3
4 quarters
|
|
|
RACB
724
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $937K | 0.01% |
95,450
-9,555
| -9% | -$93.8K |
2021 Q4
3 quarters
|
|
725
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
| $935K | 0.01% |
93,581
-9,368
| -9% | -$92.8K |
2022 Q1
2 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q3 2022 Portfolio in Review
As of Q3 2022, UBS O'Connor held 1,086 positions worth $8.8B, down 8.5% from $9.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
UBS O'Connor withdrew a net $1.49B in Q3 2022, closing 126 positions and reducing 630 holdings. Its most notable exit was American Campus Communities, Inc., an estimated $463M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS O'Connor opened a new position in Avalara, Inc. worth $373M.
- UBS O'Connor's largest Q3 2022 buy was Avalara, Inc.: 4,065,318 shares worth $373M.
- UBS O'Connor added most to ZENDESK INC in Q3 2022, an estimated $355M increase.
- UBS O'Connor's biggest Q3 2022 reduction was TSMC, cutting an estimated $77.7M.
- UBS O'Connor fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $463M.
- UBS O'Connor's ten largest holdings make up 37% of its $8.8B portfolio in Q3 2022.
- UBS O'Connor opened 112 new positions and closed 126 in Q3 2022.
- UBS O'Connor's portfolio value fell 8.5% quarter-over-quarter to $8.8B.
Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.